Under the three-year research partnership, the scientists from both companies will work together at Emulate's labs in Boston and use organ-chips to test the efficacy and safety of new antibody therapeutics
and combination therapies.
The global monoclonal antibody therapeutics
market segmentation is based on source type (chimeric and humanized, human, murine, others), therapy type (antibody-directed enzyme prodrug therapy, antibody-drug conjugates, radioimmunotherapy), application (autoimmune diseases, cancer, hematological diseases, infection, ophthalmological diseases, others), and end user (hospitals, private clinics, research institutes).
As interest in antibody therapeutics
continues to grow, Oxford BioTherapeutics is rapidly establishing itself as a partner of choice for the development of next generation cancer treatments, supported by our world-leading targeting technology and in-house pipeline of novel antibody-drug conjugates.
This number of collaborations for R/D in next-generation antibody therapeutics
arGEN-X is creating first and best in class antibody therapeutics
with highly differentiated target product profiles.
uniquely identifies, develops and manufactures novel antibody therapeutics
to alleviate human suffering in cancer, pain, cardiovascular and autoimmune and inflammatory disease areas.
Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics
for the potential treatment of cancer.
ARIUS is a biotechnology company that discovers and develops antibody therapeutics
Xencor, which develops protein and antibody therapeutics
, said the financing, which includes an initial $6 million bridge financing that the company announced in July, will be used to advance the clinical development of two biologic drug compounds, a first-in-class protein therapeutic and a novel antibody drug candidate.
3 mil) in Perseus Proteomics, a Tokyo-based bio venture company specializing in antibody therapeutics
, through a private placement.
Birmingham-based law firm Wragge & Co has advised 3i Group on its investment in domain antibody therapeutics
Genmab specialises in the creation and development of differentiated antibody therapeutics
for the treatment of cancer.
Cell Medica, a leader in developing, marketing and manufacturing cellular therapeutics for cancer and viral infections, announced today the acquisition of Delenex Therapeutics AG, a privately held, clinical stage biopharmaceutical company focused on the development of locally and systemically applied antibody therapeutics
OmniAb will provide ABBA with industry-leading technology for generation of novel antibody therapeutics
to further their therapeutic strategy," said John Higgins, chief executive officer of Ligand.